Alarelin Acetate Microspheres for Injection(Shanghai Livzon Pharma)

注射用醋酸丙氨瑞林微球（上海丽珠制药）

Report date: 2025/07/31 15:52:25

Base Information

Drug NameAlarelin Acetate Microspheres for Injection(Shanghai Livzon Pharma)
Drug Alias Name醋酸阿拉瑞林丙氨瑞林阿拉瑞林注射用醋酸丙氨瑞林微球（2.2类改良型）
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGonadotropin-releasing hormone receptor agonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsEndometriosisProstatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Livzon Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Livzon Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsEndometriosisProstatic NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A